Compare Novartis with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NOVARTIS vs SANCO INDUSTRIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NOVARTIS SANCO INDUSTRIES NOVARTIS/
SANCO INDUSTRIES
 
P/E (TTM) x 85.8 -0.5 - View Chart
P/BV x 2.7 0.3 944.1% View Chart
Dividend Yield % 1.3 0.0 -  

Financials

 NOVARTIS   SANCO INDUSTRIES
EQUITY SHARE DATA
    NOVARTIS
Mar-21
SANCO INDUSTRIES
Mar-20
NOVARTIS/
SANCO INDUSTRIES
5-Yr Chart
Click to enlarge
High Rs77023 3,311.8%   
Low Rs5016 8,350.0%   
Sales per share (Unadj.) Rs154.536.4 424.6%  
Earnings per share (Unadj.) Rs8.50.3 2,980.1%  
Cash flow per share (Unadj.) Rs13.40.8 1,731.4%  
Dividends per share (Unadj.) Rs10.000-  
Avg Dividend yield %1.60-  
Book value per share (Unadj.) Rs289.235.3 819.1%  
Shares outstanding (eoy) m24.6910.28 240.2%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x4.10.4 1,023.1%   
Avg P/E ratio x75.151.6 145.5%  
P/CF ratio (eoy) x47.518.9 251.0%  
Price / Book Value ratio x2.20.4 530.3%  
Dividend payout %118.10-   
Avg Mkt Cap Rs m15,691150 10,432.7%   
No. of employees `000NANA-   
Total wages/salary Rs m1,08514 7,761.8%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m3,814374 1,019.7%  
Other income Rs m33217 2,008.5%   
Total revenues Rs m4,146391 1,061.5%   
Gross profit Rs m26711 2,465.8%  
Depreciation Rs m1225 2,412.7%   
Interest Rs m7719 396.9%   
Profit before tax Rs m4003 13,527.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1910 382,800.0%   
Profit after tax Rs m2093 7,157.5%  
Gross profit margin %7.02.9 241.8%  
Effective tax rate %47.81.6 3,010.5%   
Net profit margin %5.50.8 702.9%  
BALANCE SHEET DATA
Current assets Rs m9,224943 978.4%   
Current liabilities Rs m3,573728 490.9%   
Net working cap to sales %148.257.5 257.9%  
Current ratio x2.61.3 199.3%  
Inventory Days Days176267 66.0%  
Debtors Days Days37348 10.7%  
Net fixed assets Rs m2,480296 836.9%   
Share capital Rs m123103 120.0%   
"Free" reserves Rs m7,018260 2,697.4%   
Net worth Rs m7,141363 1,967.2%   
Long term debt Rs m0121 0.0%   
Total assets Rs m11,7031,239 944.6%  
Interest coverage x6.21.2 538.9%   
Debt to equity ratio x00.3 0.0%  
Sales to assets ratio x0.30.3 108.0%   
Return on assets %2.41.8 135.9%  
Return on equity %2.90.8 364.3%  
Return on capital %6.74.6 144.8%  
Exports to sales %9.30-   
Imports to sales %00-   
Exports (fob) Rs m354NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m3540-   
Fx outflow Rs m9740-   
Net fx Rs m-6210-   
CASH FLOW
From Operations Rs m-69219 -3,663.8%  
From Investments Rs m95218 5,434.6%  
From Financial Activity Rs m-368-20 1,853.9%  
Net Cashflow Rs m-10917 -655.6%  

Share Holding

Indian Promoters % 0.0 44.2 -  
Foreign collaborators % 70.7 0.0 -  
Indian inst/Mut Fund % 0.8 0.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 29.3 55.8 52.6%  
Shareholders   45,141 6,162 732.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NOVARTIS With:   ABM INTERNATIONAL  TOHEAL PHARMA  RAMGOPAL POL  ASHNISHA INDUSTRIES  THACKER & CO.  



Today's Market

Bloodbath on Dalal Street: 6 Reasons Why Sensex Slumped 1,688 Points Today(Closing)

Indian share markets witnessed negative trading activity throughout the day today and ended deep in the red.

Related Views on News

NOVARTIS Announces Quarterly Results (3QFY20); Net Profit Down 39.9% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, NOVARTIS has posted a net profit of Rs 77 m (down 39.9% YoY). Sales on the other hand came in at Rs 1 bn (down 13.4% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

NOVARTIS Announces Quarterly Results (3QFY20); Net Profit Down 39.9% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, NOVARTIS has posted a net profit of Rs 77 m (down 39.9% YoY). Sales on the other hand came in at Rs 1 bn (down 13.4% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

More Views on News

Most Popular

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake(Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

How to Hit Rs 100 Crore Wealth in Your Lifetime(Equitymaster Wealth)

Nov 15, 2021

This is how you can achieve the ambitious goal of a net worth of Rs 100 crore.

Don't Sell these Stocks if the Market Falls(Profit Hunter)

Nov 17, 2021

These are the 3 types of stocks that you should not sell in a market crash.

MobiKwik IPO Opens for Subscription Soon. Key Things to Know Before Subscribing.(Views On News)

Nov 20, 2021

The Rs 19 bn issue is set to hit the market soon.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

NOVARTIS SHARE PRICE


Nov 26, 2021 (Close)

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NOVARTIS 8-QTR ANALYSIS

COMPARE NOVARTIS WITH

MARKET STATS